A New Anti-liver-kidney Microsome Antibody (anti-LKM2) in Tienilic Acid-induced Hepatitis

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1984 Mar 1

PMID 6368059

Citations 28

Authors

J C HOMBERG

C Andre

N Abuaf

Affiliations

Soon will be listed here.

Abstract

The sera of 131 patients with anti-liver-kidney microsome antibodies (anti-LKM) detected between 1973 and 1979 in two different laboratories were re-examined. (1) Eighty-six anti-LKM corresponded to the description given by Rizzetto, Swana & Doniach (1973), with a pattern of fluorescence predominating on the 3rd portion of the proximal tubules (P3). This group comprised 45 cases of idiopathic chronic hepatitis or idiopathic cirrhosis and one case of halothane-induced hepatitis. (2) Forty-five anti-LKM gave a different pattern on male mouse liver and male rat kidney: (a) fluorescence was greater on centrolobular than on periportal hepatocytes; (b) the first and second portions of proximal tubules (P1 and P2) predominated over P3; (c) P1 fluorescence was equally intense as P2 and (d) P3 cells were heterogeneous with one cell out of 20 more positive than the rest. Absorption tests confirmed that the corresponding antigen was also present in the liver microsomal fraction. A retrospective clinical study discovered tienilic acid-induced hepatitis in all cases. We suggest naming this new antibody 'anti-LKM2'.

Citing Articles

An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.

Hisamochi A, Kage M, Ide T, Arinaga-Hino T, Amano K, Kuwahara R J Gastroenterol. 2015; 51(6):597-607.

PMID: 26519284 DOI: 10.1007/s00535-015-1131-7.

Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease.

Kapila N, Higa J, Longhi M, Robson S J Clin Transl Hepatol. 2015; 1(2):79-86.

PMID: 26356124 PMC: 4521285. DOI: 10.14218/JCTH.2013.00015.

Mechanism-based inactivation of CYP450 enzymes: a case study of lapatinib.

Ho H, Chan J, Hardy K, Chan E Drug Metab Rev. 2015; 47(1):21-8.

PMID: 25639891 PMC: 4661142. DOI: 10.3109/03602532.2014.1003648.

Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.

Koen Y, Sarma D, Williams T, Galeva N, Obach R, Hanzlik R Chem Res Toxicol. 2012; 25(5):1145-54.

PMID: 22462724 PMC: 3358484. DOI: 10.1021/tx300103j.

Development of an in vitro system with human liver microsomes for phenotyping of CYP2C9 genetic polymorphisms with a mechanism-based inactivator.

Flora D, Tracy T Drug Metab Dispos. 2011; 40(4):836-42.

PMID: 22205778 PMC: 3310422. DOI: 10.1124/dmd.111.043372.

References

Allison A, DENMAN A, Barnes R . Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971; 2(7716):135-40. DOI: 10.1016/s0140-6736(71)92306-3. View

MAAS D, SCHUBOTHE H . [Lupus erythematosus-like syndrome with antimitochondrial antibodies]. Dtsch Med Wochenschr. 1973; 98(4):131-9. DOI: 10.1055/s-0028-1106763. View

Cox K, Keast D . Erythrocyte autoantibodies induced in mice immunized with rat erythrocytes. Immunology. 1973; 25(3):531-9. PMC: 1423073. View

Rizzetto M, Swana G, Doniach D . Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973; 15(3):331-44. PMC: 1553909. View

Smith M, Williams R, Walker G, Rizzetto M, Doniach D . Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J. 1974; 2(5910):80-4. PMC: 1610709. DOI: 10.1136/bmj.2.5910.80. View

Rizzetto M, Bianchi F, Doniach D . Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology. 1974; 26(3):589-601. PMC: 1423214. View

Grob P, Hacki M, Joller-Jemelka H . Drug-induced pseudolupus. Lancet. 1975; 2(7926):144-8. DOI: 10.1016/s0140-6736(75)90055-0. View

Walton B, Simpson B, Strunin L, Doniach D, Perrin J, Appleyard A . Unexplained hepatitis following halothane. Br Med J. 1976; 1(6019):1171-6. PMC: 1639695. DOI: 10.1136/bmj.1.6019.1171. View

Schmidt G, Kienle J, Schmidt D, Wolf H . [Liver diseases with microsomal antibodies. Frequency, clinical and immunological findings and course observations (author's transl)]. Z Gastroenterol. 1978; 16(8):512-20. View

10.

GROUSSIN P, Chavanne D, Renard J, Medelsi M, Royere D . [Cytolytic hepatitis, role of tienilic acid]. Med Chir Dig. 1979; 8(5):463-5. View

11.

Vergani D, Mieli-Vergani G, Alberti A, Neuberger J, Eddleston A, Davis M . Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980; 303(2):66-71. DOI: 10.1056/NEJM198007103030202. View

12.

Poupon R, HOMBERG J, Abuaf N, Petit J, Bodin F, DARNIS F . [Tienilic acid-induced hepatitis associated with liver/kidney microsomal antibody (author's transl)]. Nouv Presse Med. 1980; 9(27):1881-4. View

13.

MECHALI D, Marche C, Metayer J, Saimot G, Matheron S, Rozenbaum W . [Hepatic necrosis secondary to tienilic acid therapy (author's transl)]. Therapie. 1980; 35(2):197-203. View

14.

Bousquet O, Saigot T, Bernard P, Gerbal J, Sarrazin A . [Hepatitis during treatment with tienilic acid (author's transl)]. Therapie. 1980; 35(2):205-8. View

15.

DANGOUMAU J, Begaud B, Boisseau A, Albin H . [Methods for identification and imputation of drug side effects. Side effects: a fleeing reality, an illusive reality? (author's transl)]. Therapie. 1980; 35(3):287-92. View

16.

Volta U, Ballardini G, Cassani F, Zauli D, Bianchi F, Pisi E . [Chronic active hepatitis with antibodies against liver and kidney microsomes]. Med Chir Dig. 1980; 9(6):465-9. View

17.

Pariente E, Andre C, Zafrani E, Metreau J, Dhumeaux D, Berthelot P . [Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)]. Gastroenterol Clin Biol. 1981; 5(5):567-71. View

18.

Walli F, Grob P . [Pseudo-(venocuran-)lupus--a minor episode in the history of medicine]. Schweiz Med Wochenschr. 1981; 111(38):1398-405. View

19.

Neuberger J, Mieli-Vergani G, Tredger J, Davis M, Williams R . Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut. 1981; 22(8):669-72. PMC: 1420052. DOI: 10.1136/gut.22.8.669. View

20.

HOMBERG J, Stelly N, Andreis I, Abuaf N, Saadoun F, Andre J . A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis. Clin Exp Immunol. 1982; 47(1):93-102. PMC: 1536357. View